Briefing
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma
In the Hong Kong two-round screening cohort, first-round EBV DNA fragmentomics plus quantity identified participants with an 87.1-fold higher relative risk of developing NPC at the second round, compared with PCR-negative participants.
- Design: Evidence level 2
- Assay: Not named in the abstract